Biotricity, Inc.
NASDAQ:BTCY
0.3574 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 12.063 | 9.639 | 7.65 | 3.385 | 1.418 | 0.398 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 3.707 | 4.197 | 3.08 | 2.112 | 0.932 | 0.338 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 8.356 | 5.442 | 4.57 | 1.273 | 0.486 | 0.06 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.693 | 0.565 | 0.597 | 0.376 | 0.343 | 0.15 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 2.572 | 3.23 | 2.745 | 2.059 | 1.363 | 1.309 | 1.763 | 1.138 | 1.143 | 0.023 | 0.054 |
| General & Administrative Expenses
| 14.613 | 17.622 | 18.562 | 12.565 | 10.053 | 7.343 | 5.961 | 4.804 | 3.987 | 0.056 | 0.029 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 14.613 | 17.622 | 18.562 | 12.565 | 10.053 | 7.343 | 5.961 | 4.804 | 3.987 | 0.056 | 0.029 |
| Other Expenses
| -0.084 | -0.182 | -1.141 | -0.067 | 0.017 | 0 | 0 | 0 | 0 | -0.001 | -0.001 |
| Operating Expenses
| 17.185 | 20.852 | 21.307 | 14.625 | 11.416 | 8.652 | 7.724 | 5.942 | 5.13 | 0.09 | 0.09 |
| Operating Income
| -8.828 | -15.592 | -17.877 | -13.419 | -10.914 | -8.592 | -7.724 | -5.942 | -5.13 | -0.09 | -0.091 |
| Operating Income Ratio
| -0.732 | -1.618 | -2.337 | -3.964 | -7.698 | -21.577 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -5.266 | -0.666 | -1.824 | 0.342 | -0.044 | -0.012 | -0.021 | -0.689 | 0.004 | -0.001 | -0.001 |
| Income Before Tax
| -14.094 | -18.658 | -29.13 | -15.491 | -11.067 | -8.592 | -8.624 | -7.809 | -5.186 | -0.091 | -0.091 |
| Income Before Tax Ratio
| -1.168 | -1.936 | -3.808 | -4.577 | -7.806 | -21.577 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.835 | 2.401 | 9.429 | 2.067 | -0.039 | -0.172 | -6.844 | -4.764 | 0.051 | -0.001 | -0.001 |
| Net Income
| -14.094 | -18.658 | -29.13 | -15.491 | -11.067 | -8.592 | -8.624 | -7.809 | -5.186 | -0.091 | -0.091 |
| Net Income Ratio
| -1.168 | -1.936 | -3.808 | -4.577 | -7.806 | -21.577 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.57 | -2.15 | -3.85 | -2.48 | -1.85 | -1.54 | -1.72 | -1.81 | -1.42 | -0.061 | -0.061 |
| EPS Diluted
| -1.57 | -2.15 | -3.85 | -2.48 | -1.85 | -1.54 | -1.72 | -1.81 | -1.42 | -0.061 | -0.061 |
| EBITDA
| -8.456 | -15.586 | -17.875 | -13.419 | -10.914 | -8.592 | -7.724 | -5.942 | -5.13 | -0.09 | -0.09 |
| EBITDA Ratio
| -0.701 | -1.617 | -2.337 | -3.964 | -7.698 | -21.577 | 0 | 0 | 0 | 0 | 0 |